Both in Biotechnology
IN8bio vs Intensity Therapeutics
Over the past year INAB returned −51.4% and INTS returned −46.3%; their daily moves had a correlation of 0.07.
INAB −51.4% INTS −46.3%Growth of $1, one year, split-adjusted
| Metric | INAB | INTS |
|---|---|---|
| Price | $1.02 | $3.38 |
| Market cap | $10.1M | $11.0M |
| Today | +6.25% | +6.29% |
| 1 month | −21.2% | −1.2% |
| 6 months | −32.5% | −34.4% |
| Year to date | −56.4% | −67.0% |
| 1 year | −51.4% | −44.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $17.8M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 82.1% | 62.5% |
| Short % of float | 0.5% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).